Synucleins

Encyclopedia of Neuroscience

Volumn , Issue , 2009, Pages 833-837

  Chandra, S ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

Amyloid; Lewy body; Neurodegeneration; Parkinson's disease; Presynaptic; Synuclein

Indexed keywords

EID: 84876511972     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008045046-9.01354-1     Document Type: Chapter

References (17)

1. Abeliovich A., Schmitz Y., Farinas I., et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 2000, 25:239-252.
2. Chandra S., Gallardo G., Fernandez-Chacon R., Schluter O.M., Sudhof T.C. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 2005, 123:383-396.
3. Clayton D.F., George J.M. The synucleins: A family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends in Neurosciences 1998, 21:249-254.
4. Conway K.A., Lee S.J., Rochet J.-C., Ding T.T., Williamson R.E., Lansbury P.T. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:571-576.
5. Dauer W., Kholodilov N., Vila M., et al. Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:14524-14529.
6. Dauer W., Przedborski S. Parkinson's disease: Mechanisms and models. Neuron 2003, 39:889-909.
7. Feany M.B., Bender W.W. A Drosophila model of Parkinson's disease. Nature 2000, 404:394-398.
8. Iwai A., Masliah E., Yoshimoto M., et al. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 1995, 14:467-475.
9. Jao C.C., Der-Sarkissian A., Chen J., Langen R. Structure of membrane-bound alpha-synuclein studied by site-directed spin labeling. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:8331-8336.
10. Ji H., Liu Y.E., Jia T., et al. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Research 1997, 57:759-764.
11. Kruger R., Kuhn W., Muller T., et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nature Genetics 1998, 18:106-108.
12. Lee V.M.-Y., Trojanowski J.Q. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: New targets for drug discovery. Neuron 2006, 52:33-38.
13. Manning-Bog A.B., McCormack A.L., Purisai M.G., Bolin L.M., Di Monte D.A. Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration. Journal of Neuroscience 2003, 23:3095-3099.
14. Polymeropoulos M.H., Lavedan C., Leroy E., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
15. Singleton A.B., Farrer M., Johnson J., et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003, 302:841.
16. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997, 388:839-840.
17. Ulmer T.S., Bax A., Cole N.B., Nussbaum R.L. Structure and dynamics of micelle-bound human alpha-synuclein. Journal of Biological Chemistry 2005, 280:9595-9603.